-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on NOV, Lowers Price Target to $11

Benzinga·04/30/2025 22:25:02
Listen to the news
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and lowers the price target from $13 to $11.